125 related articles for article (PubMed ID: 2846525)
1. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor.
Lucore CL; Fujii S; Wun TC; Sobel BE; Billadello JJ
J Biol Chem; 1988 Nov; 263(31):15845-8. PubMed ID: 2846525
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.
Hopkins WE; Westerhausen DR; Sobel BE; Billadello JJ
Nucleic Acids Res; 1991 Jan; 19(1):163-8. PubMed ID: 2011496
[TBL] [Abstract][Full Text] [Related]
3. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
Sawdey M; Podor TJ; Loskutoff DJ
J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579
[TBL] [Abstract][Full Text] [Related]
4. Mediators of induction of augmented expression of plasminogen activator inhibitor type-1 in Hep G2 cells by platelets.
Hopkins WE; Westerhausen DR; Fujii S; Billadello JJ; Sobel BE
Thromb Haemost; 1991 Aug; 66(2):239-45. PubMed ID: 1663280
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells.
Keski-Oja J; Raghow R; Sawdey M; Loskutoff DJ; Postlethwaite AE; Kang AH; Moses HL
J Biol Chem; 1988 Mar; 263(7):3111-5. PubMed ID: 3125175
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
Heaton JH; Gelehrter TD
Mol Endocrinol; 1989 Feb; 3(2):349-55. PubMed ID: 2469009
[TBL] [Abstract][Full Text] [Related]
8. Synergistic induction of plasminogen activator inhibitor type-1 in HEP G2 cells by thrombin and transforming growth factor-beta.
Hopkins WE; Fujii S; Sobel BE
Blood; 1992 Jan; 79(1):75-81. PubMed ID: 1309426
[TBL] [Abstract][Full Text] [Related]
9. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2.
Alessi MC; Juhan-Vague I; Kooistra T; Declerck PJ; Collen D
Thromb Haemost; 1988 Dec; 60(3):491-4. PubMed ID: 3149048
[TBL] [Abstract][Full Text] [Related]
10. Regulation of plasminogen activator inhibitor-1 and -2 messenger ribonucleic acid levels in human cumulus and granulosa-luteal cells.
Piquette GN; Crabtree ME; el-Danasouri I; Milki A; Polan ML
J Clin Endocrinol Metab; 1993 Feb; 76(2):518-23. PubMed ID: 8432798
[TBL] [Abstract][Full Text] [Related]
11. Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells.
Westerhausen DR; Hopkins WE; Billadello JJ
J Biol Chem; 1991 Jan; 266(2):1092-100. PubMed ID: 1985937
[TBL] [Abstract][Full Text] [Related]
12. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
Niedbala MJ; Sartorelli AC
Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
[TBL] [Abstract][Full Text] [Related]
13. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
Bergonzelli GE; Kruithof EK
J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
[TBL] [Abstract][Full Text] [Related]
14. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.
Owensby DA; Morton PA; Wun TC; Schwartz AL
J Biol Chem; 1991 Mar; 266(7):4334-40. PubMed ID: 1705551
[TBL] [Abstract][Full Text] [Related]
15. Constitutive plasminogen activator inhibitor 1 (PAI-1) biosynthesis in human Hep G2 hepatoma cells is maintained by an autocrine factor.
Bergonzelli GE; Kruithof EK
Thromb Haemost; 1991 Aug; 66(2):222-5. PubMed ID: 1663279
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
Lund LR; Riccio A; Andreasen PA; Nielsen LS; Kristensen P; Laiho M; Saksela O; Blasi F; Danø K
EMBO J; 1987 May; 6(5):1281-6. PubMed ID: 3111844
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
[TBL] [Abstract][Full Text] [Related]
18. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
19. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
Cohen RL; Niclas J; Lee WM; Wun TC; Crowley CW; Levinson AD; Sadler JE; Shuman MA
J Biol Chem; 1989 May; 264(14):8375-83. PubMed ID: 2498314
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell line.
George F; Pourreau-Schneider N; Arnoux D; Boutière B; Dussault N; Roux-Dosseto M; Alessi MC; Martin PM; Sampol J
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):689-93. PubMed ID: 2133249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
